Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Estrogen synthesis is the multi-step biochemical process by which estrogens, a class of steroid hormones, are produced from cholesterol-derived precursors. Key enzymes include aromatase (CYP19A1), which converts androgens (androstenedione and testosterone) into estrogens (estradiol, estrone, and estriol). This pathway is crucial for regulating reproductive function, development, and various non-reproductive tissues. Dysregulation contributes to diseases like hormone-dependent cancers and osteoporosis. Aromatase inhibitors are used therapeutically to block estrogen synthesis.
Inhibition of aromatase, preventing the conversion of androgens to estrogens
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Estrogen Synthesis.